We do not give medical information nor personal recommendation of any product, treatment or point of view on these pages. We simply collate information that may be of interest.
Hydroxychloroquine (HCQ) is an inexpensive medication (Plaquinel) recommended by the WHO to treat malaria and is also used to treat lupus. American soldiers such as Lt Gen Michael Flynn, have successfully taken this medication for years as a prophylaxis. It has been used by Dr Vladimir Zelenko as part of his successful treatment for coronavirus and was recommended for use by President Donald Trump who did not catch covid-19 until after he stopped taking hyroxychloroquine.
COVID-19 treatment studies for Hydroxychloroquine – www.c19early.com – Database of all HCQ COVID-19 studies. 362 studies, 265 peer reviewed, 296 comparing treatment and control groups. Early treatment consistently shows positive effects and late treatments less effectiveness. Negative evaluations typically ignore treatment time, often focusing on a subset of late stage studies. In Vitro evidence made some believe that therapeutic levels would not be attained, however that was incorrect
Dr Zelenko’s Covid-19 Prohylaxis Protocol – Prophylaxis is an action taken to prevent or protect against a specified disease
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study – International Journal of Antimicrobial Agents – “Risk stratification-based treatment of COVID-19 outpatients as early as possible after symptom onset using triple therapy, including the combination of zinc with low-dose hydroxychloroquine, was associated with significantly fewer hospitalisations.”
Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study – BMC infectious Diseases – “In this retrospective observational study of SARS-CoV-2 infected non-hospitalized patients hydroxychloroquine exposure was associated with a decreased rate of subsequent hospitalization.”
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection – The American Journal of Medicine – “COVID-19 hospitalizations and death can be reduced with outpatient treatment”
Hydroxychloroquine is effective, and consistently so when provided early, for COVID-19: a systematic review – Science Direct – “HCQ was found to be consistently effective against COVID-19 when provided early in the outpatient setting. It was also found to be overall effective in inpatient studies. No unbiased study found worse outcomes with HCQ use. No mortality or serious safety adverse events were found. HCQ is consistently effective against COVID-19 when provided early in the outpatient setting, it is overall effective against COVID-19, it has not produced worsening of disease and it is safe.”